Ofatumumab

ATC L04AG12 · 11 markets · 27 records

Ofatumumab 11 markets · 27 records Forms

AU 8 records · 3 strengths

  • 20 mg/0.4 mLinjectionKESIMPTA also in GB·SG·US +1
  • 50 mg/mLinjectionBonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled penBonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled syringe、Kesimpta ofatumumab 20 mg/0.4mL solution for injection pre-filled pen、Kesimpta ofatumumab 20 mg/0.4mL solution for injection pre-filled syringe、ZOPHEOS ofatumumab 20 mg/0.4mL solution for injection pre-filled pen、ZOPHEOS ofatumumab 20 mg/0.4mL solution for injection pre-filled syringe unknown

Records without a stated strength · 1 KESIMPTA

GB 3 records · 3 strengths

CA 2 records · 1 strengths

SG 2 records · 1 strengths

US 1 records · 1 strengths

CN 1 records · 1 strengths

ES 1 records · 1 strengths

MX 1 records · 1 strengths

    Records without a stated strength · 1 BONSPRI

    TW 1 records · 1 strengths

    HK 1 records · 1 strengths

      Records without a stated strength · 1 KESIMPTA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20MG/0.4ML

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 KESIMPTA

        Also called: 奥法木单抗、奧法木單抗 nickname

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.